Nexam Chemical Holding Past Earnings Performance
Past criteria checks 0/6
Nexam Chemical Holding's earnings have been declining at an average annual rate of -7.7%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 11.2% per year.
Key information
-7.7%
Earnings growth rate
-1.9%
EPS growth rate
| Chemicals Industry Growth | 32.9% |
| Revenue growth rate | 11.2% |
| Return on equity | -10.7% |
| Net Margin | -10.8% |
| Next Earnings Update | 12 Jul 2024 |
Recent past performance updates
Recent updates
Earnings Release: Here's Why Analysts Cut Their Nexam Chemical Holding AB (publ) (STO:NEXAM) Price Target To kr4.00
Feb 03
Nexam Chemical Holding AB (publ)'s (STO:NEXAM) Subdued P/S Might Signal An Opportunity
Dec 07Estimating The Fair Value Of Nexam Chemical Holding AB (publ) (STO:NEXAM)
Jul 05Nexam Chemical Holding (STO:NEXAM) Has Debt But No Earnings; Should You Worry?
Jun 08Is Nexam Chemical Holding (STO:NEXAM) Using Debt In A Risky Way?
Mar 14Nexam Chemical Holding (STO:NEXAM) Has Debt But No Earnings; Should You Worry?
Jun 01Analysts Are Optimistic We'll See A Profit From Nexam Chemical Holding AB (publ) (STO:NEXAM)
Apr 20Estimating The Fair Value Of Nexam Chemical Holding AB (publ) (STO:NEXAM)
Feb 28What Kind Of Shareholders Hold The Majority In Nexam Chemical Holding AB (publ)'s (STO:NEXAM) Shares?
Feb 09
Nexam Chemical Holding's(STO:NEXAM) Share Price Is Down 17% Over The Past Five Years.
Jan 19Nexam Chemical Holding AB (publ) (STO:NEXAM): Are Analysts Optimistic?
Dec 30Is Nexam Chemical Holding (STO:NEXAM) A Risky Investment?
Dec 09Revenue & Expenses BreakdownBeta
How Nexam Chemical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 191 | -21 | 88 | 0 |
| 31 Dec 23 | 190 | -23 | 88 | 0 |
| 30 Sep 23 | 195 | -24 | 90 | 0 |
| 30 Jun 23 | 206 | -23 | 92 | 0 |
| 31 Mar 23 | 220 | -15 | 88 | 0 |
| 31 Dec 22 | 222 | -13 | 87 | 0 |
| 30 Sep 22 | 223 | -10 | 84 | 0 |
| 30 Jun 22 | 217 | -9 | 80 | 0 |
| 31 Mar 22 | 221 | -7 | 80 | 0 |
| 31 Dec 21 | 219 | -5 | 79 | 0 |
| 30 Sep 21 | 209 | -7 | 78 | 0 |
| 30 Jun 21 | 200 | -6 | 76 | 0 |
| 31 Mar 21 | 177 | -8 | 68 | 0 |
| 31 Dec 20 | 166 | -8 | 65 | 0 |
| 30 Sep 20 | 151 | -11 | 63 | 0 |
| 30 Jun 20 | 141 | -14 | 60 | 0 |
| 31 Mar 20 | 140 | -13 | 60 | 0 |
| 31 Dec 19 | 130 | -17 | 59 | 0 |
| 30 Sep 19 | 128 | -15 | 56 | 0 |
| 30 Jun 19 | 122 | -17 | 57 | 0 |
| 31 Mar 19 | 115 | -17 | 55 | 0 |
| 31 Dec 18 | 110 | -17 | 53 | 0 |
| 30 Sep 18 | 90 | -4 | 51 | 0 |
| 30 Jun 18 | 66 | -2 | 41 | 0 |
| 31 Mar 18 | 43 | -5 | 36 | 0 |
| 31 Dec 17 | 19 | -6 | 29 | 0 |
| 30 Sep 17 | 11 | -21 | 24 | 0 |
| 30 Jun 17 | 10 | -22 | 25 | 0 |
| 31 Mar 17 | 10 | -22 | 25 | 0 |
| 31 Dec 16 | 8 | -22 | 24 | 0 |
| 30 Sep 16 | 9 | -19 | 19 | 0 |
| 30 Jun 16 | 12 | -16 | 27 | 0 |
| 31 Mar 16 | 8 | -16 | 24 | 0 |
| 31 Dec 15 | 8 | -22 | 24 | 0 |
| 30 Sep 15 | 6 | -29 | 44 | 0 |
| 30 Jun 15 | 2 | -34 | 34 | 0 |
| 31 Mar 15 | 2 | -38 | 34 | 0 |
| 31 Dec 14 | 2 | -35 | 32 | 0 |
| 30 Sep 14 | 0 | -33 | 28 | 0 |
| 30 Jun 14 | 1 | -31 | 28 | 0 |
| 31 Mar 14 | 2 | -28 | 27 | 0 |
| 31 Dec 13 | 3 | -27 | 27 | 0 |
| 30 Sep 13 | 2 | -23 | 20 | 0 |
| 30 Jun 13 | 2 | -21 | 20 | 0 |
Quality Earnings: NEXAM is currently unprofitable.
Growing Profit Margin: NEXAM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEXAM is unprofitable, and losses have increased over the past 5 years at a rate of 7.7% per year.
Accelerating Growth: Unable to compare NEXAM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEXAM is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19%).
Return on Equity
High ROE: NEXAM has a negative Return on Equity (-10.75%), as it is currently unprofitable.